Aplazar Tablet is a nutritional supplement primarily used for managing chronic kidney disease (CKD) in its early stages, namely stages I, II, and III. Developed by Steadfast Medishield Pvt Ltd, this combination medicine falls under the category of nutritional supplements.
In addition to its main role in CKD management, this tablet is also utilised to help reduce the formation of urea and the accumulation of uremic toxins. This action helps delay the progression of CKD and can potentially lead to an improved quality of life for patients.
When startingthis tablet, it's important to consult your doctor to determine the correct dosage and frequency. Inform your doctor about any pre-existing conditions or ongoing medications before beginning this supplement. If you notice any side effects while on this medicine, notify your doctor immediately.